ABSTRACT OBJECTIVES This study sought to determine whether epicardial adipose tissue (EAT) volume predicts the progression of coronary artery calcification (CAC) score in the general population.
picardial adipose tissue (EAT) is associated with cardiovascular risk factors, coronary artery plaque burden, and prevalent cardiovascular disease (1) (2) (3) .
Moreover, it is associated with future cardiovascular events independent of traditional cardiovascular risk factors, suggesting that EAT may influence atherosclerosis development, potentially via its inflammatory modulating effect (4) (5) (6) (7) .
Besides a controversial association with calcific plaque burden (1, 6) , a strong association of EAT with noncalcified plaque components was reported (2, 8) . Together with a more pronounced association of EAT with future coronary events in subjects with no or low coronary artery calcification (CAC) (6) , these results support the hypothesis of a mechanistic role of EAT in the early phase of atherosclerosis. First studies suggested that EAT may promote CAC progression in selected cohorts (9) (10) (11) . However, to date, data from an asymptomatic general population cohort to confirm these results is lacking. Therefore, the aim of the current analysis was to determine whether EAT predicts progression of CAC in a European population-based cohort over a period of 5 years.
METHODS
STUDY PARTICIPANTS. The Heinz Nixdorf Recall study is a population-based, prospective cohort study designed to assess the predictive value of novel markers for risk stratification in addition to traditional cardiovascular risk factors. The participants (45 to 75 years of age) were randomly selected from mandatory lists of residence from the 3 adjacent cities of Bochum, Essen, and Mülheim, Germany, and were enrolled between 2000 and 2003, with a recruitment efficacy of 55.8%. Details for recruitment and study design have been previously published (12, 13) . For this analysis, we excluded subjects with known coronary artery disease at baseline (n ¼ 327) or revascularization between baseline and follow-up examination (n ¼ 154). Additionally, 159 subjects died before follow-up examination, and 407 subjects did not participate in the follow-up examination. A total of 246 subjects were excluded due to missing CAC score at baseline or follow-up examination. EAT volume or 1 or more risk factors were missing in 154 subjects, resulting in a total cohort of 3,367 subjects. All participants provided written informed consent, and the study was approved by the institutional ethics committee.
CARDIOVASCULAR RISK FACTOR ASSESSMENT.
Traditional cardiovascular risk factors were measured at baseline, with details being previously published (14) . Body mass index (BMI) was calculated on the basis of direct measurements as the weight divided by the square of height. Waist circumference was measured at the leanest circumference between the costal arch and the iliac crest. Blood pressure was measured using an oscillometric method (Omron, Hoofddorp, the Netherlands). The mean value of the second and third of 3 measurements taken at least 2 min apart were used. Standardized enzymatic methods were used to determine serum high-density lipoprotein (HDL) cholesterol and lowdensity lipoprotein (LDL) cholesterol. Diabetes was defined as a history of diabetes, being on medical treatment, or on the basis of blood glucose levels, as previously published (15) . Smoking history was classified as current smokers, former smokers, and no history of smoking, assessed by computerassisted interview (16) . A positive family history of coronary heart disease was defined as premature nonfatal or fatal coronary heart disease diagnosis. An event was considered premature if it occurred before 55 years of age in men and before 65 years of age in women (17) . If ancestors were unknown or died early (e.g., in the Second World War), or if information was missing, subjects were classified as not having positive family history.
CARDIAC COMPUTED TOMOGRAPHY. As part of the study, subjects underwent cardiac computed tomography (CT) for quantification of CAC. Electron beam computed tomography scans were performed utilizing a C-100 or C-150 scanner (GE Imatron, South San Francisco, California) without the use of contrast media. Imaging was prospectively triggered at 80% of the RR interval, and contiguous 3-mm-thick slices from the right pulmonary artery to the apex of the heart were obtained at an image acquisition time of 100 ms. Follow-up imaging was performed with identical scanning protocol, using an Imatron C-150 scanner. CAC was defined as a focus of at least 4 contiguous pixels with a CT density >130 Hounsfield units (HU) and quantified using the Agatston method (18) . Participants and physicians remained unaware of the CAC scoring results of the baseline examination.
EPICARDIAL FAT VOLUME QUANTIFICATION. Epicardial fat volume was assessed using a dedicated SD of EAT volume as previously described for EAT, leading to easy-to-understand effect sizes (3, 6) . In addition, identical regression analyses were performed using waist circumference instead of BMI in all models. Besides sex-pooled analysis, sex-specific analysis was also performed, including a test of interaction between EAT and sex. Further, regression analysis was stratified by CAC score at baseline, using the following CAC groups: 0, >0 to <100, $100 to <400, and $400. In addition to the progression of log-transformed CAC scores, we calculated regression analyses of EAT with the difference of square root of CAC at follow-up and the square root of CAC at baseline, using identical models. Also, we stratified regression analysis by age at baseline using the following age groups: <55, $55 to 65, and $65 years of age. To assess the effect in different BMI groups and rule out modeling effects of BMI and EAT due to their correlation, we further investigated the association of 
RESULTS
Overall, 3,367 subjects (mean age 59 AE 8 years; 47% male) were included in this analysis, with detailed characteristics of the study cohort depicted in Table 1 . Median CAC score at baseline was 7.0 When stratifying by CAC group at baseline, we observed significantly higher CAC scores at followup for all CAC groups except for CAC $400 (CAC ¼ 0: n¼ 1,224; CAC >0 to <100: n ¼ 1,335; CAC $100
to <400: n ¼ 541; CAC $400: n ¼ 267).
EAT VOLUME AND CAC PROGRESSION. association was found for subjects with a CAC of $100 to <400 with 8% (95% CI: 3% to 13%; p ¼ 
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FIGURE 2 EAT-Attributable Progression in CAC by CAC Group at Baseline
Regression analysis for the association of EAT volume with CAC progression as stratified by CAC score at baseline, revealing that those subjects with low CAC score at baseline showed highest EAT-attributable CAC progression. *Multivariate (MV) adjustment included age, sex, body mass index (BMI), systolic blood pressure, antihypertensive medication, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, lipid-lowering medication, triglyceride, diabetes, present smoking, and former smoking. Abbreviations as in Figure 1 . Table 4) . Sex-specific analysis revealed no relevant sex difference for the association of EAT with onset of CAC (detailed data not shown).
DISCUSSION
In the present analysis, we describe a link between Over the last decade, several studies investigated a potential link of epicardial and pericardial adipose Depicted as % progression of CAC þ 1 per each SD of EAT.
CI ¼ confidence interval; other abbreviations as in Table 1 . Therefore, we were unable to detect noncalcified plaque components and are not able to make any conclusion on whether EAT may lead to progression of vulnerable plaques. Baseline CAC score is a predictor of CAC progression. Therefore, analysis of EAT on CAC progression may be impacted by baseline CAC. However, we performed several additional approaches including analyses in subgroups of CAC score at baseline, which confirmed the results. As a further limitation, our study is based on a predominantly Caucasian population; hence, generalizability to other ethnic groups remains uncertain. Last, in our analysis, we excluded subjects with revascularization during follow-up due to uncertainties on the quantification of CAC after stent implantation or bypass surgery, which may have led to a selection bias.
CONCLUSIONS
EAT volume is associated with CAC progression after 5 years, especially in young subjects and subjects with low CAC score at baseline, independent of traditional cardiovascular risk factors. These findings support the hypothesis that EAT promotes early atherosclerosis development.
